Cefazolin Injection, Powder, Lyophilized, For Solution
Product Images NDC 66288-1100

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cefazolin (NDC 66288-1100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Samson Medical Technologies, L.l.c., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Bag Image)

Figure (Bag Image)
An illustration labeled SMARTPAK INNER BAG depicting a bag with two eyelets, seals, a double seal, a label area, a transfer port with threaded cap and flange, a reconstitution port, and a cap. The diagram outlines components related to a medical or pharmaceutical container system for preparing or transferring injectable solutions.*
FDA Label Image

Principal Display Panel – 100 G Inner Bag Label (Cefazolin 100g Inner Bag)

Principal Display Panel – 100 G Inner Bag Label (Cefazolin 100g Inner Bag)
Label of CEFAZOLIN Injection USP Pharmacy Bulk Package by Samson Medical Technologies, featuring 100 grams of sterile, nonpyrogenic, preservative-free cefazolin sodium powder for solution. The label highlights the product is for intravenous use only, not for direct infusion, and not to be dispensed as a unit. Storage and handling instructions, including discarding the diluted bag within 4 hours after initial entry, are detailed, along with a concentration and volume table for reconstitution with sterile water for injection.*
FDA Label Image

Principal Display Panel – 100 G Outer Bag Label (Cefazolin 100g Outer Bag)

Principal Display Panel – 100 G Outer Bag Label (Cefazolin 100g Outer Bag)
Label for CEFAZOLIN injection, USP, pharmacy bulk package containing 100 grams of cefazolin sodium powder for intravenous use. The label states it is sterile, nonpyrogenic, preservative-free, and not for direct infusion or dispensing as a unit. It includes storage instructions, dilution guidelines, and manufacturer information for Samson Medical Technologies, L.L.C. The packaging specifies the approximate concentration as 1 gram per 10 mL with 960 mL sterile water for injection.*
FDA Label Image

Principal Display Panel – 300 G Inner Bag Label (Cefazolin 300g Inner Bag)

Principal Display Panel – 300 G Inner Bag Label (Cefazolin 300g Inner Bag)
Label for CEFAZOLIN injection, USP, 300 grams pharmacy bulk package for intravenous use. The lyophilized powder is sterile, nonpyrogenic, preservative-free, and supplied by Samson Medical Technologies, L.L.C. The label highlights the package is not for direct infusion or dispensing as a unit, with storage and usage instructions including discarding within 4 hours after initial entry.*
FDA Label Image

Principal Display Panel – 300 G Outer Bag Label (Cefazolin 300g Outer Bag)

Principal Display Panel – 300 G Outer Bag Label (Cefazolin 300g Outer Bag)
Label for CEFAZOLIN Injection, USP, a pharmacy bulk package containing 300 grams of lyophilized powder for intravenous use. The label emphasizes it is not for direct infusion and must not be dispensed as a unit. Manufactured by Samson Medical Technologies, L.L.C., the label includes storage and handling instructions and a table indicating a concentration of 1 gram per 10 mL with 2880 mL sterile water for injection.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of cefazolin sodium, displayed as a molecular diagram showing its atomic connectivity and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.